DEXTROPROPOXYPHENE
Unresolved issues with global drug regulators to hit Wockhardt's performanceWockhardt's June quarter performance was its worst in the past five quarters. Net sales remained almost flat and net profit dropped 14.5%.
Wockhardt's stock plummets 8% today; not an opportunity to buyThis is the third major jolt to the company, whose stock has already corrected 54% in last three months.
Gvernment bans sale of painkillerThe government has banned the sale of pain-relieving medicine, dextropropoxyphene, in a move that is expected to impact pharma companies' b...
Pharma products being smuggled outside India are misused: International Narcotics Control BoardPharmaceutical preparations containing narcotic drugs continue to be diverted from Indian pharma firms and smuggled into South Asian countr...- Pharmaceutical drug abuse increasing in India: UN0Pharmaceutical drug abuse is increasing in South Asia, particularly India a trend the UN says will increase the risk of diseases like HIV/A...
- Wockhardt gets US FDA nod to mkt painkillers in USWockhardt Ltd today said it has got US FDA approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate a...
Load More